氯碳头孢与头孢克洛治疗女性尿路感染的比较。
Loracarbef versus cefaclor in the treatment of urinary tract infections in women.
作者信息
Iravani A
机构信息
Department of Pediatrics, College of Medicine, University of Florida, Gainesville 32610-0296.
出版信息
Antimicrob Agents Chemother. 1991 Apr;35(4):750-2. doi: 10.1128/AAC.35.4.750.
Abstract
In a double-blind, prospective, randomized study, 108 college women with acute urinary tract infections were treated for 7 days with either loracarbef (LY163892) at 200 mg once daily (n = 53) or cefaclor at 250 mg three times daily (n = 55). The cure rates at 5 to 9 days after treatment in the loracarbef and cefaclor groups were 96 and 90%, respectively. Both loracarbef and cefaclor are safe, well tolerated, and effective in the treatment of urinary tract infections in women.
摘要
在一项双盲、前瞻性、随机研究中，108名患有急性尿路感染的大学女性被给予以下两种治疗方案，为期7天：每日一次服用200毫克氯碳头孢（LY163892）（n = 53），或每日三次服用250毫克头孢克洛（n = 55）。氯碳头孢组和头孢克洛组在治疗后5至9天的治愈率分别为96%和90%。氯碳头孢和头孢克洛在治疗女性尿路感染方面均安全、耐受性良好且有效。
相似文献
1
Loracarbef versus cefaclor in the treatment of urinary tract infections in women.
Antimicrob Agents Chemother. 1991 Apr;35(4):750-2. doi: 10.1128/AAC.35.4.750.
2
Loracarbef versus cefaclor in the treatment of cystitis and asymptomatic bacteriuria.
Clin Ther. 1992 Jan-Feb;14(1):54-63.
3
Loracarbef (LY163892) versus cefaclor in the treatment of acute bacterial bronchitis.
Clin Ther. 1992 Jan-Feb;14(1):41-53.
4
Loracarbef (LY163892) versus cefaclor in the treatment of bacterial skin and skin-structure infections in an adult population.
Am J Med. 1992 Jun 22;92(6A):80S-85S. doi: 10.1016/0002-9343(92)90613-g.
5
Antibiotic therapy for urinary tract infections.
Am J Med. 1992 Jun 22;92(6A):95S-100S. doi: 10.1016/0002-9343(92)90615-i.
6
Loracarbef (LY163892) versus cefaclor and norfloxacin in the treatment of uncomplicated pyelonephritis.
Am J Med. 1992 Jun 22;92(6A):86S-94S. doi: 10.1016/0002-9343(92)90614-h.
7
Comparison of cefprozil and cefaclor for treatment of acute urinary tract infections in women.
Antimicrob Agents Chemother. 1991 Sep;35(9):1940-2. doi: 10.1128/AAC.35.9.1940.
8
Cefprozil versus cefaclor in the treatment of acute and uncomplicated urinary tract infections. Cefprozil Multicenter Study Group.
Clin Ther. 1992 Mar-Apr;14(2):314-26.
9
Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infection.
Clin Ther. 2000 Jul;22(7):818-25. doi: 10.1016/s0149-2918(00)80054-5.
10
Comparative efficacy and safety of cefprozil and cefaclor in the treatment of acute uncomplicated urinary tract infections.
J Antimicrob Chemother. 1991 Oct;28(4):581-6. doi: 10.1093/jac/28.4.581.
引用本文的文献
1
Loracarbef. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.
Drugs. 1993 May;45(5):716-36. doi: 10.2165/00003495-199345050-00008.
2
Comparison of cefprozil and cefaclor for treatment of acute urinary tract infections in women.
Antimicrob Agents Chemother. 1991 Sep;35(9):1940-2. doi: 10.1128/AAC.35.9.1940.
本文引用的文献
1
Maximum utilization of the life table method in analyzing survival.
J Chronic Dis. 1958 Dec;8(6):699-712. doi: 10.1016/0021-9681(58)90126-7.
2
Urinary tract infection caused by Staphylococcus saprophyticus.
J Infect Dis. 1980 Oct;142(4):510-5. doi: 10.1093/infdis/142.4.510.
3
Treatment of urinary tract infections with a combination of amoxicillin and clavulanic acid.
Antimicrob Agents Chemother. 1982 Oct;22(4):672-7. doi: 10.1128/AAC.22.4.672.
4
Treatment of acute uncomplicated urinary tract infections by cephalexin, with special reference to the antibody-coated bacteria.
Int J Clin Pharmacol Ther Toxicol. 1982 Mar;20(3):97-100.
5
Treatment of uncomplicated urinary tract infections with trimethoprim versus sulfisoxazole, with special reference to antibody-coated bacteria and fecal flora.
Antimicrob Agents Chemother. 1981 May;19(5):842-50. doi: 10.1128/AAC.19.5.842.
6
A comparison of cefaclor versus trimethoprim-sulfamethoxazole combination in the treatment of acute urinary infections.
J Urol. 1981 Feb;125(2):228-9. doi: 10.1016/s0022-5347(17)54981-2.
7
Prospective comparison of amoxicillin-clavulanic acid and cefaclor in treatment of uncomplicated urinary tract infections.
Antimicrob Agents Chemother. 1983 Nov;24(5):716-9. doi: 10.1128/AAC.24.5.716.
8
Antibiotic susceptibility testing by a standardized single disk method.
Am J Clin Pathol. 1966 Apr;45(4):493-6.
9
API system: a multitube micromethod for identification of Enterobacteriaceae.
Appl Microbiol. 1972 Sep;24(3):449-52. doi: 10.1128/am.24.3.449-452.1972.
10
Cefuroxime axetil in the treatment of uncomplicated UTI: a comparison with cefaclor and augmentin.
Drugs Exp Clin Res. 1987;13(2):95-9.
Zotero 插件